Company Filing History:
Years Active: 2019-2020
Title: Sudharsan Sridharan: Innovator in Biopharmaceuticals
Introduction
Sudharsan Sridharan is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative patents. With a total of 2 patents, his work focuses on developing novel therapeutic approaches.
Latest Patents
One of his latest patents is titled "P2X4 antibodies and uses thereof." This invention provides antibodies that specifically bind to a P2X4 polypeptide and modulate P2X4 channel activity. It also includes recombinant P2X4 polypeptides and methods for generating such polypeptides. Additionally, it outlines compositions and methods for generating anti-P2X4 antibodies, as well as their application in treating neuropathic pain and other indications. Another significant patent is for "GITRL fusion proteins comprising a human coronin 1a derived trimerization domain." This disclosure provides GITRL fusion polypeptide subunits that include an IgG Fc domain, a trimerization domain, and the receptor binding domain of GITR ligand. These fusion polypeptide subunits can self-assemble into hexameric proteins, with methods of making these proteins and their applications, such as cancer treatment.
Career Highlights
Sudharsan works at Medimmune Limited, where he continues to push the boundaries of biopharmaceutical research. His innovative spirit and dedication to advancing medical science have made him a valuable asset to his company and the industry.
Collaborations
He collaborates with notable colleagues, including Wendy A Williams and Clare Jones, who contribute to his research endeavors and help bring his inventions to fruition.
Conclusion
Sudharsan Sridharan exemplifies the spirit of innovation in the biopharmaceutical sector. His patents and ongoing research are paving the way for new treatments and therapies that could significantly impact patient care.